We are pleased to share that as of today Friday September 4th 21411 participants have been enrolled in the COVE Phase 3 study of mRNA-1273. Find out more about the trial here: https://t.co/fWw97I7C3J. Check back next Friday evening for an updated enrollment number. https://t.co/SlLqh2crdh